NCT00471211View on ClinicalTrials.gov

Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

PBT2

Trial Locations (15)

85

Lund

2031

Sydney

2077

Sydney

3081

Melbourne

3101

Melbourne

3146

Melbourne

3199

Melbourne

5011

Adelaide

521 85

Falköping

952 81

Kalix

391 85

Kalmar

205 20

Malmo

112 98

Stockholm

901 85

Umeå

751 85

Uppsala

Sponsors
All Listed Sponsors
lead

Prana Biotechnology Limited

INDUSTRY